bronopol has been researched along with Dermatitis, Atopic in 2 studies
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaughnessy, CN | 1 |
| Malajian, D | 1 |
| Belsito, DV | 1 |
| Maibach, HI | 1 |
2 other studies available for bronopol and Dermatitis, Atopic
| Article | Year |
|---|---|
Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives.
Topics: Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Hydantoins; I | 2014 |
Dermal sensitization potential of 2-bromo-2-nitropropane-1,3-diol (Bronopol).
Topics: Dermatitis, Atopic; Dose-Response Relationship, Drug; False Positive Reactions; Humans; Patch Tests; | 1977 |